9-109167006-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014334.4(FRRS1L):​c.133C>A​(p.Arg45Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000787 in 1,229,646 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0041 ( 7 hom., cov: 25)
Exomes 𝑓: 0.00033 ( 4 hom. )

Consequence

FRRS1L
NM_014334.4 missense

Scores

1
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.36

Publications

0 publications found
Variant links:
Genes affected
FRRS1L (HGNC:1362): (ferric chelate reductase 1 like) This gene encodes a component of the outer-core of an alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor protein in the brain. The encoded protein is thought to interact with inner-core components of the receptor, and play a role in the modulation of glutamate signaling. Mutations in this gene are associated with early infantile epileptic encephalopathy 37. [provided by RefSeq, Jul 2016]
FRRS1L Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 37
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004635483).
BP6
Variant 9-109167006-G-T is Benign according to our data. Variant chr9-109167006-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 476301.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00407 (607/149224) while in subpopulation AFR AF = 0.0142 (580/40970). AF 95% confidence interval is 0.0132. There are 7 homozygotes in GnomAd4. There are 276 alleles in the male GnomAd4 subpopulation. Median coverage is 25. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRRS1LNM_014334.4 linkc.133C>A p.Arg45Ser missense_variant Exon 1 of 5 ENST00000561981.5 NP_055149.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRRS1LENST00000561981.5 linkc.133C>A p.Arg45Ser missense_variant Exon 1 of 5 1 NM_014334.4 ENSP00000477141.2
FRRS1LENST00000642299.1 linkn.-75C>A upstream_gene_variant ENSP00000495137.1
FRRS1LENST00000644747.1 linkn.-3C>A upstream_gene_variant ENSP00000493964.1

Frequencies

GnomAD3 genomes
AF:
0.00408
AC:
608
AN:
149126
Hom.:
7
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.0142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00126
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000299
Gnomad OTH
AF:
0.00292
GnomAD2 exomes
AF:
0.000523
AC:
2
AN:
3826
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0161
Gnomad AMR exome
AF:
0.00165
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000334
AC:
361
AN:
1080422
Hom.:
4
Cov.:
33
AF XY:
0.000309
AC XY:
159
AN XY:
514696
show subpopulations
African (AFR)
AF:
0.0142
AC:
316
AN:
22314
American (AMR)
AF:
0.000696
AC:
6
AN:
8624
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13698
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25320
South Asian (SAS)
AF:
0.00
AC:
0
AN:
22744
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22542
Middle Eastern (MID)
AF:
0.000348
AC:
1
AN:
2870
European-Non Finnish (NFE)
AF:
0.0000109
AC:
10
AN:
919542
Other (OTH)
AF:
0.000655
AC:
28
AN:
42768
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00407
AC:
607
AN:
149224
Hom.:
7
Cov.:
25
AF XY:
0.00379
AC XY:
276
AN XY:
72804
show subpopulations
African (AFR)
AF:
0.0142
AC:
580
AN:
40970
American (AMR)
AF:
0.00126
AC:
19
AN:
15062
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3430
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4978
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4770
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9932
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.0000299
AC:
2
AN:
66806
Other (OTH)
AF:
0.00289
AC:
6
AN:
2076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
25
50
76
101
126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000349
Hom.:
0
Bravo
AF:
0.00462

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FRRS1L: BS1, BS2

Feb 15, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

FRRS1L-related disorder Benign:1
Aug 14, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Developmental and epileptic encephalopathy, 37 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
22
DANN
Benign
0.96
DEOGEN2
Benign
0.017
T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.30
N
LIST_S2
Benign
0.48
T
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L
PhyloP100
2.4
PrimateAI
Pathogenic
0.93
D
Sift4G
Benign
0.79
T
Vest4
0.36
ClinPred
0.0052
T
GERP RS
0.59
PromoterAI
-0.024
Neutral
Varity_R
0.21
gMVP
0.39
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs573029562; hg19: chr9-111929286; API